welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
How Patient Groups have Begun to Influence the Value and Coverage Debate
source: Health Affairs Blog
year: 2016
authors: Margaret Anderson, Kristin Schneeman
summary/abstract:In 2015, two issues related to medicine could be relied on to generate headlines: drug pricing and the proliferation of new value frameworks that claimed to define the value and even the price of drugs in seemingly easy-to-understand ways. In none of the high-profile skirmishes on pricing or frameworks was the voice or perspective of patients and patient groups very much in evidence. But that is beginning to change, in an evolution of a broader shift in the role that patients are playing in the research and development (R&D) enterprise.
read moreexpertly curated content related to this topic
-
Arnold J. Markowitz, MDArnold J. Markowitz is a board-certified...
-
Susan K. Peterson, PhD, MPHDr. Susan K. Peterson is a member at The...
-
Hulda Einarsdottir, MDHulda Einarsdottir is an Assistant Profe...
-
Adam H. Buchanan, MS, MPH, CGCGenetic Counselor Specializations: Fa...
-
shawna morrisonBoard Certified Genetic Counsellor...
-
life’s a polypI'm Jenny and I was diagnosed with Famil...
-
Steven M. Lipkin, MD, PhDDr. Lipkin is a board certified Clinical...